Tabori U - Search Results

1

Telomere dysfunction and chromothripsis.

Ernst A, Jones DT, Maass KK, Rode A, Deeg KI, Jebaraj BM, Korshunov A, Hovestadt V, Tainsky MA, Pajtler KW, Bender S, Brabetz S, Gröbner S, Kool M, Devens F, Edelmann J, Zhang C, Castelo-Branco P, Tabori U, Malkin D, Rippe K, Stilgenbauer S, Pfister SM, Zapatka M, Lichter P. Ernst A, et al. Among authors: tabori u. Int J Cancer. 2016 Jun 15;138(12):2905-14. doi: 10.1002/ijc.30033. Epub 2016 Feb 29. Int J Cancer. 2016. PMID: 26856307 Free article.

2

Low prevalence of complications in severe neutropenic children with cancer in the unprotected environment of an overnight camp.

Tabori U, Jones H, Malkin D. Tabori U, et al. Pediatr Blood Cancer. 2007 Feb;48(2):148-51. doi: 10.1002/pbc.20757. Pediatr Blood Cancer. 2007. PMID: 16421908

3

Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.

Tabori U, Ma J, Carter M, Zielenska M, Rutka J, Bouffet E, Bartels U, Malkin D, Hawkins C. Tabori U, et al. J Clin Oncol. 2006 Apr 1;24(10):1522-8. doi: 10.1200/JCO.2005.04.2127. J Clin Oncol. 2006. PMID: 16575002

4

The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas.

Tabori U, Vukovic B, Zielenska M, Hawkins C, Braude I, Rutka J, Bouffet E, Squire J, Malkin D. Tabori U, et al. Neoplasia. 2006 Feb;8(2):136-42. doi: 10.1593/neo.05715. Neoplasia. 2006. PMID: 16611406 Free PMC article.

5

Toxicity and outcome of children with treatment related acute myeloid leukemia.

Tabori U, Revach G, Nathan PC, Strahm B, Rachlis A, Shago M, Grant R, Doyle J, Malkin D. Tabori U, et al. Pediatr Blood Cancer. 2008 Jan;50(1):17-23. doi: 10.1002/pbc.21157. Pediatr Blood Cancer. 2008. PMID: 17252569

6

Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.

Tabori U, Nanda S, Druker H, Lees J, Malkin D. Tabori U, et al. Cancer Res. 2007 Feb 15;67(4):1415-8. doi: 10.1158/0008-5472.CAN-06-3682. Cancer Res. 2007. PMID: 17308077

7

Telomere biology of pediatric cancer.

Tabori U, Dome JS. Tabori U, et al. Cancer Invest. 2007 Apr-May;25(3):197-208. doi: 10.1080/07357900701208683. Cancer Invest. 2007. PMID: 17530490 Review.

8

Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li-Fraumeni syndrome.

Tabori U, Malkin D. Tabori U, et al. Cancer Res. 2008 Apr 1;68(7):2053-7. doi: 10.1158/0008-5472.CAN-07-2091. Cancer Res. 2008. PMID: 18381406 Review.

9

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome.

Shlien A, Tabori U, Marshall CR, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer SW, Malkin D. Shlien A, et al. Among authors: tabori u. Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11264-9. doi: 10.1073/pnas.0802970105. Epub 2008 Aug 6. Proc Natl Acad Sci U S A. 2008. PMID: 18685109 Free PMC article.

10

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma.

Tabori U, Wong V, Ma J, Shago M, Alon N, Rutka J, Bouffet E, Bartels U, Malkin D, Hawkins C. Tabori U, et al. Br J Cancer. 2008 Oct 7;99(7):1129-35. doi: 10.1038/sj.bjc.6604652. Epub 2008 Sep 16. Br J Cancer. 2008. PMID: 18797459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page